This module provides advanced training in the area of medicines produced by biotechnology. Participants will study the new therapeutic technologies that are in development as well as the ethical and regulatory frameworks that apply to these products. The differences between the clinical development programmes required by these different technologies will also be explored. The areas covered include recombinant proteins, monoclonal antibodies, vaccines, both prophylactic and therapeutic, gene therapy, stem cells and epigenetics.
Module assessment - more information